I hope you are right but i wonder how you arrive at valuations of multiple billions of dollars when currently targetting rhetinitis pigmentosa, with some other possible targets down the track. surely until they can demonstrate applications with more diverse target markets the mc will remain a fraction of 1 billion. I thought 1 billion was the target market and if tgey captured that completely the company still wouldnt ve worth 1 billion or am i missing how companies are generally vslued. Is anyone suggesting 3 billion is possible to you or us that just your opinion? Hope you dont mind me askng.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)